Article thumbnail

Effects of bevacizumab plus irinotecan on response and survival in patients with recurrent malignant glioma: a systematic review and survival-gain analysis

By Tao Xu, Juxiang Chen, Yicheng Lu and Johannes EA Wolff
Publisher: 'Springer Science and Business Media LLC'
Year: 2010
DOI identifier: 10.1186/1471-2407-10-252
OAI identifier:
Provided by: MUCC (Crossref)

Suggested articles


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.